Improved Rankings, Upcoming Conference Presentations, and Launch of New Products - Analyst Notes on Centene, BD, Boston Scientific, Community Health Systems and CareFusion

NEW YORK, June 6, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Centene Corporation (NYSE: CNC), Becton, Dickinson and Co. (NYSE: BDX), Boston Scientific Corporation (NYSE: BSX), Community Health Systems, Inc. (NYSE: CYH) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3417-100free.

--
Centene Corporation Analyst Notes
On June 2, 2014, Centene Corporation (Centene) announced that it has moved to rank No. 251 from No. 303 last year in FORTUNE Magazine's annual ranking of America's largest companies by revenue. Centene stated that it experienced strong growth in 2013, creating opportunities that also broadened its geographic and product diversity. The Company added that in 2013, Centene increased its revenue growth by 37.0% YoY with several significant expansion opportunities. It entered two new States, California and New Hampshire; experienced significant organic growth in other markets; added two new specialty companies, AcariaHealth and USMM (U.S. Medical Management); and entered into the health insurance marketplace in nine states and the correctional healthcare services market in two states. The full analyst notes on Centene are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/CNC/report.pdf

--
Becton, Dickinson and Co. Analyst Notes
On May 29, 2014, Becton, Dickinson and Co. (BD) announced that it will present at the Goldman Sachs 35th Annual Global Healthcare Conference on June 10, 2014, at 1:40 p.m. ET. BD stated that a live webcast of the presentation can be accessed at BD's corporate website, and its replay will be available after the conclusion of the conference for a period of seven days. The full analyst notes on BD are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/BDX/report.pdf

--
Boston Scientific Corporation Analyst Notes
On June 3, 2014, Boston Scientific Corporation (Boston Scientific) announced that the Company is scheduled to participate in the Wells Fargo 2014 Healthcare Conference on June 17, 2014 in Boston, MA. The Company informed that its Executive Vice President and CFO, Dan Brennan, and Vice President of Investor Relations, Susan Lisa, will participate in a 30-minute question and answer session about the Company at the Healthcare Conference at approximately 8:50 a.m. ET. Boston Scientific also informed that the live webcast of the question and answer session can be accessed through its website, and that a replay of the same will be archived and available one hour after the completion of the session. The full analyst notes on Boston Scientific are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/BSX/report.pdf

--
Community Health Systems, Inc. Analyst Notes
On June 3, 2014, Community Health Systems, Inc. (Community Health Systems) announced that its management will participate at the Goldman Sachs 35th Annual Global Healthcare Conference, to be held from June 10 - 12, 2014, at the Terranea Resort, Rancho Palos Verdes, California. According to the Company, the investor presentation will commence at 10:00 a.m. PT (12:00 p.m. CT) on Tuesday, June 10, 2014; and a live webcast of the presentation will be accessible through the Company's website. A replay will also be available for a period of 30 days at the same location. The full analyst notes on Community Health Systems are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/CYH/report.pdf

--
CareFusion Corporation Analyst Notes
On June 2, 2014, CareFusion Corporation (CareFusion) announced that it will launch three new products that have been designed to help reduce surface contamination or the presence of microorganisms that can cause infections during hospital stays and procedures. The products will be launched at the 41st Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC). The three new products are as follows: the ChloraPrep® 1mL applicator - a new addition to the ChloraPrep line of preoperative skin preparation products which provides clinicians with a unique applicator design and the same formulation they know and trust in a new 1 mL size; the ChrloraShield® IV dressing with chlorhexidine gluconate (CHG) antimicrobial - a flexible and breathable dressing that enhances patient care during vascular access procedures; and the MaxZero™ - a new extension to a proprietary portfolio of needleless connectors, designed to help improve patient safety and promote nursing best practices. The full analyst notes on CareFusion are available to download free of charge at:

http://www.analystsreview.com/Jun-06-2014/CFN/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review